Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
GTP Solution in mRNA Synthesis: Protocols & Troubleshooting
2026-06-12
High-purity GTP Solution (100 mM) empowers robust in vitro mRNA synthesis for advanced therapeutics, including p21 mRNA-LNP delivery in bladder cancer. Discover protocol refinements, practical troubleshooting, and evidence-based insights that set APExBIO's GTP Solution apart for translational research.
-
Aminopeptidase Inhibition Modulates Angiotensin Activity in
2026-06-12
This study demonstrates that the conversion of angiotensin II to angiotensin III is essential for neuronal activation in the rat brain, and that aminopeptidase inhibitors such as bestatin and amastatin differentially regulate this process. The findings clarify the enzymatic control of neuropeptide signaling, with implications for research on neural, cardiovascular, and peptide-mediated pathways.
-
Optimizing Cell Proliferation Assays with Murine Recombinant
2026-06-11
Murine recombinant PDGF-BB is a gold-standard mitogen for robust, reproducible cell proliferation assays in smooth muscle and connective tissue research. Discover protocol refinements, troubleshooting strategies, and translational insights from pulmonary hypertension research to elevate your experimental outcomes.
-
Cimetidine as a Histamine-2 Receptor Antagonist in BBB & Can
2026-06-11
Cimetidine's unique partial agonist profile and robust solubility empower researchers with reproducible results in blood-brain barrier and gastrointestinal cancer models. Leveraging APExBIO's high-purity compound, advanced workflows now integrate Cimetidine to interrogate H2 receptor signaling and antitumor effects with improved precision.
-
Propranolol: Applied Workflows for β-Adrenergic Blockade Res
2026-06-10
Propranolol from APExBIO empowers researchers to achieve reliable β-adrenergic receptor inhibition across cardiovascular, neurobehavioral, and metabolic models. This guide details optimized protocols, troubleshooting insights, and translational advantages drawn from the latest human and preclinical evidence.
-
Cyanine 5-dCTP: Precision Fluorescent DNA Labeling for EOS
2026-06-10
Cyanine 5-dCTP enables high-sensitivity, red-fluorescent DNA labeling, empowering researchers to push the boundaries of enzymatic oligonucleotide synthesis and nucleic acid detection. Leveraging the latest advances in ordered DNA framework interfaces, this guide details how to optimize Cy5-dCTP workflows for maximum yield, fidelity, and troubleshooting efficiency.
-
Two Decades of Toremifene: Advances in Breast Cancer Endocri
2026-06-09
This review synthesizes 20 years of clinical experience with toremifene, a selective estrogen receptor modulator (SERM), in the treatment of breast cancer. The paper provides key insights into the pharmacological rationale, efficacy, and safety profile of toremifene, highlighting its role within personalized medicine and biomarker-driven therapeutic strategies.
-
Laminin (925-933): Technical Guide for Cell Adhesion Assays
2026-06-09
Laminin (925-933) is a synthetic peptide derived from the laminin B1 chain, optimized for cell adhesion and chemotaxis assays in extracellular matrix research. It addresses the need for defined, receptor-specific tools to dissect cell migration and basement membrane interactions. Not for diagnostic or in vivo therapeutic use; applicability is limited to scientific research contexts.
-
6-Thioguanine Blocks EV71 by Targeting BIRC3-Mediated Autoph
2026-06-08
This study reveals that 6-thioguanine (6-TG), an established antineoplastic agent, potently inhibits Enterovirus 71 (EV71) replication in vitro by disrupting BIRC3-mediated autophagy. These findings provide mechanistic insight and a foundation for potential therapeutic development against EV71-related hand, foot, and mouth disease.
-
Salmonella Haem Biosynthesis Undermines Macrophage Defense
2026-06-08
This study uncovers a mechanism by which Salmonella Typhimurium boosts its haem production to evade macrophage phagocytosis, thereby enhancing its virulence in mice. The findings reveal that methyltransferase-mediated modification of haem biosynthetic enzymes is central to immune evasion, providing new avenues for infection biology and heme pathway research.
-
Astrocytic GAT-3 Shapes Synaptic Transmission in Dentate Gyr
2026-06-07
This study reveals that astrocytic GAT-3 modulates synaptic transmission and memory formation within the dentate gyrus by regulating intracellular calcium and presynaptic receptor activity. The findings clarify a key glial-neuronal mechanism underpinning cognitive processing and offer new directions for targeted synaptic transmission research.
-
Bufalin as a Precision Tool: Mechanistic Insights for Oncolo
2026-06-06
Explore how Bufalin, a cardiotonic steroid, enables precision targeting in cancer research. This article delivers a unique mechanistic analysis and practical guidance for translational oncology workflows.
-
Cytoskeleton-Dependent Mechanotransduction in Autophagy
2026-06-05
Liu et al. (2024) provide direct evidence that the cytoskeleton, especially microfilaments, is essential for the induction of autophagy by mechanical stress in human cells. This mechanistic insight refines our understanding of how cells translate physical forces into autophagic signaling, with significant implications for designing targeted assays in cancer and cell biology research.
-
HDAC Inhibition Reverses EBV-Induced Dedifferentiation in NP
2026-06-05
This study uncovers how HDAC inhibition can reverse Epstein-Barr virus (EBV)-driven dedifferentiation in nasopharyngeal carcinoma (NPC) by restoring CEBPA expression, thus reducing cancer cell plasticity. The findings offer a mechanistic framework for differentiation therapy in solid tumors and highlight the importance of targeting epigenetic regulators to overcome therapeutic resistance.
-
Verteporfin in Photodynamic Therapy: Protocols and Innovatio
2026-06-04
Verteporfin (CL 318952) stands out in photodynamic therapy and autophagy research with dual-action versatility. This article unpacks stepwise protocols, advanced applications, and troubleshooting strategies—backed by recent mechanobiology insights—to ensure high-reproducibility outcomes in both ocular and oncology models.